1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China

1/11/2021VISEN Pharma Closes $150M Series B Financing for Novel Endocrinology D...

1/11/2021Novartis and BeiGene in $2.2B Deal Latter's Promising Checkpoint Inhi...

1/11/2021Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...

1/11/2021Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...

1/11/2021Chipscreen Files Pivotal PIII Trial IND Submission for Anticancer Chia...

1/11/2021NHSA Issues Two Interim Rules for Management of BMI Designated Medical...

1/8/2021VISEN Pharma Granted IND Approval for P2 Trial of Achondroplasia Drug...

1/8/2021Allecra and Haini Pharma Enter Licensing Deal for Cefepime/Enmetazob...

1/8/2021Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...

1/8/2021HLB's Liver Cancer Drug Wins Marketing Approval in China

1/8/2021Abbisko Raises $123 Million From Carlyle, Warburg

1/8/2021European Firms Eye Chinese Assets in Mainly Insurance and Healthcare...

1/8/2021Recent Executive Moves

1/8/2021SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...

1/8/2021S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...

1/7/2021Economic Burden and Health Care Access for Patients with IBD in China:...

1/7/2021China Issues Announcement on the 2021 Doping List (#51)

1/7/2021Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...

1/6/2021NHC Issues Two New Documents on Public Hospital Management

1/6/2021Eli Lilly Granted Chinese Approval of Verzenio (Abemaciclib)

1/6/2021Immedica and Winhealth Sign Deal for UCD Drug Ravicti in Greater Chin...

1/6/202125 Domestics Filed 96 ANDAs in the U.S. in 2020

1/6/2021Argenx and Zai Lab Enter Strategic Deal for Efgartigimod in Greater Ch...

1/6/2021Winhealth Pharma and TWiB Enter into Strategic Licensing Partnership o...

1/5/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...

1/5/2021Harbour BioMed Completes Its Global Offering and Listing on the HKSE

1/5/2021Terns Pharma Raises $87M in Series C Funding to Get NASH Hopefuls Thru

1/5/2021Chipscreen's Chiauranib Granted Breakthrough Therapy Designation in Ch...

1/4/2021NMPA Signs MOU on Regulatory Cooperation with Italian Medicines Agenc...

Page:205/775 Total number of articles:23243: [First][<<] [203] [204] [205] [206] [207] [>>] [End]